| Financial Year |
March 31 2023 |
| Monetary Funds |
923,598,875.76 |
| Held-for-trading Financial Assets |
465,488,055.56 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
4,597,634.16 |
| Other Receivables |
95,428,216.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
18,560,111.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,098,870.65 |
| Total Current Assets |
2,917,730,677.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,334,811.32 |
| Investment Properties |
14,329,409.03 |
| Fixed Assetes |
207,214,335.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,891,033.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
60,752,281.71 |
| Other Non-Current Assets |
274,494,428.80 |
| Sub-Total of Non-Current Assets |
567,089,325.67 |
| Total Assets |
3,484,820,003.16 |
| Short-Term Loans |
24,439,180.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
356,248,538.00 |
| Accounts Payable |
627,486,482.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
65,942,530.24 |
| Taxes Payable |
14,320,079.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,309,851.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
389,833.69 |
| Other Current Liabilities |
41,361,164.38 |
| Sub-Total of Current Liabilities |
1,194,352,712.26 |
| Long-term Loans |
-- |
| Bonds Payable |
493,732,457.16 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
67,942.42 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
495,148,732.12 |
| Total Liabilities |
1,689,501,444.38 |
| Paid-In Capital(Or Share Stock) |
181,696,635.00 |
| Capital Surplus |
796,314,029.01 |
| Surplus Reserve |
91,987,693.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
621,623,248.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,795,318,558.78 |
| Owner's Equity（Stockholder's Equity） |
1,795,318,558.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,484,820,003.16 |
